Covance sells Caprion; Euro pharma group praises EU trial proposal;

 @DamianFierce: CRO Novasep is spending $3.7M to expand its French API plant, looking to produce targeted cancer drugs. More | Follow @DamianFierce

> Covance ($CVD) has sold its stake in Caprion Proteomics to Chicago Growth Partners, Outsourcing-Pharma.com reports. Article

> The European Association of Pharmaceutical Industries and Associations lauded the EU's proposal to liberalize clinical trial regulations around the continent, saying it will create a healthy, competitive medical research environment. Statement

> Quintiles is partnering with Allscripts to use electronic health records to fuel drug development. News

> Parexel International has tabbed Mark Goldberg to be its new president. The former COO takes over for Josef von Rickenbach, who stepped down this month. Item

> German CRO ICRC-Weyer is upgrading its medical coding procedures, a move it says will allow the company to offer versatile research capabilities to its clients. Release

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

WCG is continuing its buyout run after acquiring clinical trial solutions firm Trifecta Clinical.

London-based uMed has raised nearly $4.8 million from U.K. and U.S. VCs to help healthcare providers participate in more clinical studies.

Amgen has teamed up with cloud-based trial solutions firm Reify Health to help boost patients into its drug studies.